- Shipment of medical cannabis to Israel represents a new international revenue opportunity for Supreme Cannabis
- Truverra-branded product will be sold through Israel’s largest and leading producer of medical cannabis and cannabis product
- The cannabis was grown at Supreme Cannabis’ premium, indoor, hybrid cultivation operation located in Ontario
The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a company dedicated to growing the world’s best cannabis and becoming a leader in the global cannabis industry, completed a landmark shipment of medical cannabis from Canada to Israel. The shipment contained Supreme Cannabis’ premium medical cannabis product, which will be sold through Israel’s largest and leading producer of medical cannabis and cannabis product (http://cnw.fm/8kJWr).
Supreme Cannabis interim president and CEO Colin Moore reported that the transaction, which was made possible through a partnership with Breath of Life International (BOL Pharma), represents a new international revenue opportunity for Supreme Cannabis and “builds Truverra’s global medical brand in one of the most sophisticated medical cannabis markets in the world.”
“With the support of BOL Pharma, we navigated both Canada and Israel’s complex regulatory landscapes to achieve compliance with regulatory authorities in both countries, including Health Canada, the Canadian Food Inspection Agency and Israel’s Ministry of Health and Ministry of Agriculture and Rural Development,” Moore continued. “We benefitted from BOL Pharma’s skilled team, international experience and solidified position as a leading medical cannabis company in Israel. As we pursue capital-light international opportunities, we will continue to look to Jeff Adams, Truverra’s CEO, and his exceptional team to build Truverra’s medical brand globally.”
Supreme Cannabis’ partner in Israel, BOL Pharma has been researching and developing cannabis-based products for more than a decade and is the only company in Israel that handles all stages of cultivation and production, ensuring compliance with the strictest standards set by the Israeli Ministry of Health and EU-GMP conditions.
Supreme Cannabis is exporting a differentiated offering to Israel. Truverra’s premium positioned medical product is indoor grown and distributed in 10-gram containers to BOL Pharma’s network of pharmacies across Israel. BOL Pharma’s CEO, Dr. Tamir Gedo, spoke to the strength of Supreme Cannabis as a partner and the quality of its product, noting, “Supreme Cannabis is a partner that shares our high standards for quality and respect for patients and consumers. On March 30, Truverra products became available across pharmacies in Israel, and we are already receiving positive feedback from patients. We look forward to continuing to work with Supreme Cannabis and to offering Truverra’s premium medical cannabis to patients in Israel.”
Supreme Cannabis acquired Truverra last year in an agreement designed to secure an international medical brand and strong team with unique pharmaceutical expertise (http://cnw.fm/0aZBG). The Truverra acquisition provided a capital-light entry point into Europe’s CBD wellness market, where Truverra had successfully launched multiple CBD products through its ecommerce business, Truverra.com. This landmark shipment to Israel helps to establish Truverra as an international medical cannabis brand and provides diversified revenue opportunities for Supreme Cannabis.
The Supreme Cannabis Company is a global, diversified portfolio of distinct cannabis companies, products and brands. Since 2014, SPRWF has emerged as one of the world’s fastest-growing, premium plant-driven lifestyle companies. Supreme Cannabis’ brands are backed by a focused suite of world-class operating assets that serve key functions in the value chain, including scaled cultivation, value-add processing, centralized manufacturing and product testing and research and development.
For more information, visit the company’s website at www.Supreme.ca
NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://cnw.fm/SPRWF
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]
CannabisNewsWire is part of the InvestorBrandNetwork.